cTNT release may be under the control of pro-inflammatory cytokines, such as IL-6 and TNFα (both involved in C26-related cachexia), as also suggested by studies on how pharmacological blockade of these cytokines affects cTNT levels [59,60]. The gene discussed is TNF; the disease is Cachexia.